Spero Therapeutics SPRO
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 2.33 | 98.82 | 0.56 | 31,405 | 32 | |
| 2025Q3 | 1.88 | 107.23 | -0.13 | -7,916 | -7 | |
| 2025Q2 | 2.90 | 143.76 | -0.03 | -2,444 | -2 | |
| 2025Q1 | 0.72 | 106.24 | 11.46 | -0.25 | -14,731 | -14 |
| 2024Q4 | 1.03 | 105.47 | 15.98 | -0.38 | -21,725 | -21 |
| 2024Q3 | 1.34 | 106.63 | 4.15 | -0.32 | -18,593 | -17 |
| 2024Q2 | 1.30 | 106.71 | 3.00 | -0.33 | -19,061 | -18 |
| 2024Q1 | 1.72 | 110.36 | 4.06 | -0.24 | -13,982 | -13 |
| 2023Q4 | 1.47 | 97.97 | 0.97 | 50,532 | 51 | |
| 2023Q3 | 1.21 | 194.67 | -0.06 | -1,935 | -3 | |
| 2023Q2 | 1.45 | 108.18 | -0.23 | -12,889 | -12 | |
| 2023Q1 | 1.45 | 107.24 | -0.25 | -14,227 | -13 | |
| 2022Q4 | 1.73 | 96.84 | 0.93 | 25,924 | 27 | |
| 2022Q3 | 2.00 | 101.36 | -0.28 | -11,834 | -12 | |
| 2022Q2 | 0.74 | 91.30 | -0.87 | -26,080 | -29 | |
| 2022Q1 | 8.70 | 99.56 | -1.01 | -30,207 | -33 | |
| 2021Q4 | 16.01 | 100.74 | -0.92 | -27,502 | -29 | |
| 2021Q3 | 18.41 | 100.01 | -0.70 | -22,524 | -23 | |
| 2021Q2 | 13.96 | 99.84 | -0.63 | -18,542 | -19 | |
| 2021Q1 | 14.72 | 99.90 | -0.66 | -19,403 | -19 |